文献速递瓣膜病与结构性心脏病肺血管病与心包/心肌炎

肺动脉高压与二尖瓣缘对缘修复术后结局的关联

Association of pulmonary hypertension with the outcome in patients undergoing edge-to-edge mitral valve repair.
PubMed 文献 · Heart · 2024-05-10

该回顾性分析纳入449例连续接受二尖瓣经导管缘对缘修复(M-TEER)的患者,按2015和2022年ESC/ERS指南的肺动脉高压(PH)定义进行分层。结果显示,任何类型的PH均与M-TEER术后死亡风险升高相关,且2022年新定义(mPAP>20 mmHg)比旧定义能更好区分PH分组和死亡率。

要点

  • 任何类型PH均与M-TEER术后死亡风险升高独立相关。
  • 2022年新定义(mPAP>20 mmHg)较2015年定义预后区分能力更优。
  • 侵入性测量的肺动脉压力、右房压、PVR等可预测全因死亡。

核心结论

  • 新PH定义能更好区分PH分组和死亡率,mPAP阈值20 mmHg改善了该队列的预后评估。

主要发现

  • 任何类型PH患者较无PH患者死亡风险更高:2015定义HR 1.61(95%CI 1.25-2.07),p<0.001;2022定义HR 2.09(95%CI 1.54-2.83),p<0.001。
  • 基于新定义,各PH亚组较无PH患者M-TEER术后生存率均更低。
  • 超声估测sPAP与侵入性mPAP(r=0.29,p<0.001)和sPAP(r=0.34,p<0.001)相关。
  • Cox回归显示侵入性舒张压、收缩压和平均肺动脉压越高,全因死亡率越高(p<0.001)。
  • 侵入性测量的更高右房压、更低肺动脉顺应性、更高PVR和更高楔压是全因死亡的预测因素。

关键数值与推荐

  • 2015年ESC/ERS定义:mPAP≥25 mmHg,PCWP≤15 mmHg,DPG≥7 mmHg或PVR>3 WU。
  • 2022年ESC/ERS定义:mPAP>20 mmHg,PCWP≤15 mmHg,PVR≥3 WU。

临床怎么用

  • 对接受M-TEER的患者应评估PH类型,采用2022年新定义有助于更精细的危险分层。
  • 侵入性血流动力学参数(mPAP、右房压、PVR、肺动脉顺应性、PCWP)可用于术后死亡风险预测。

局限性

  • 回顾性单中心分析,样本量449例,结果需前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The association of pulmonary hypertension (PH) with the outcome after mitral transcatheter edge-to-edge repair (M-TEER) focusing on the new ESC/ERS guidelines definition for PH. BACKGROUND: PH is frequently found in patients with mitral regurgitation and is associated with lower survival rates. Recent studies were based on echocardiographic parameters, but results based on invasive haemodynamics differentiating distinct types of PH using the new definition for PH are missing. METHODS: 449 consecutive M-TEER-treated patients from December 2009 to February 2015 were included in this retrospective analysis. All patients were stratified by the distinct types of PH (no PH, precapillary PH, isolated postcapillary PH, combined post-PH and precapillary PH) according to the definitions of the ESC/ERS guidelines for the diagnosis of PH from 2015 (meanPA cut-off <25 mm Hg, pulmonary capillary wedge pressure (PCWP) cut-off ≤15 mm Hg, diastolic pulmonary gradient cut-off ≥7 mm Hg or pulmonary vascular resistance (PVR) >3 WU) and 2022 (meanPA cut-off ≤20 mm Hg, PCWP cut-off ≤15 mm Hg, PVR cut-off ≥3 WU). RESULTS: Patients with any type of PH (2015: meanPA cut-off 25 mm Hg; 2022: meanPA cut-off >20 mm Hg) showed a higher risk of death after M-TEER compared with patients with no PH (2015: HR 1.61 (95% CI 1.25 to 2.07); p<0.001 and 2022: HR 2.09 (95% CI 1.54 to 2.83); p<0.001). Based on the new PH definition, each PH subgroup showed a lower survival after M-TEER compared with patients with no PH. Echocardiographic estimated systolic PAP showed a correlation with invasively measured mean pulmonary artery pressure (mPAP) (r=0.29, p<0.001) and systolic pulmonary arterial pressure (r=0.34,p<0.001). Cox-regression analysis showed higher invasive diastolic, systolic and mean pulmonary pressures were associated with higher all-cause mortality (p<0.001). In addition, invasive measured higher right atrial pressure, lower pulmonary arterial compliance, higher PVR and higher wedge pressure were identified as predictors of all-cause mortality after M-TEER. CONCLUSIONS: The new PH definition discriminates PH groups and mortality better than the old definition. The lower threshold of mPAP of 20mmHg improved prognostication in this cohort of patients.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Ubben T, Frerker C, Fujita B, et al. Association of pulmonary hypertension with the outcome in patients undergoing edge-to-edge mitral valve repair. Heart. 2024. PMID: 38388469. doi:10.1136/heartjnl-2023-323473

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。